Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Acta Otolaryngol Suppl ; 523: 124-7, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-9082756

RESUMEN

As has been shown earlier by us, the metabolism of extracellular deoxycytidine (dCyd) is 2-3 times higher in follicular and in PNA+ cells than in other cells. Deoxycytidine kinase (dCK) is one of the most important target enzymes for anti-proliferative drugs such as arabinosile-cytosine (ara-C), 2-Cl-deoxyadenosine (CdA). Neither the dCK activity nor the polypeptide correlates with the S phase of the cells, as thymidine kinase (TK1) does in tonsils. The newly developed anti-leukemic drug CdA, and also BrdA, are also phosphorylated by dCK and both effectively inhibit the 3H-dThd incorporation into DNA in tonsillar lymphocytes. A new molecular mechanism has been developed for CdA; it inhibits the interconversion of dCyd into dThd nucleotides. Analysis of the pools after 3H-dCyd labeling showed a decrease of the dUMP labeling. The inhibition of dCMP deaminase by the corresponding monophosphates (Cl-dAMP) in the cells has been suggested. CdA cannot be deaminated by adenosine deaminase (ADA), thus providing a good tool to investigate the importance of that enzyme during differentiation of the lymphoid cells. Elucidation of the nucleoside metabolism during the normal differentiation process might be the only way to get information about the same pathways in malignant transformations, i.e., in leukemias.


Asunto(s)
Antineoplásicos/farmacología , Cladribina/farmacología , Linfocitos/inmunología , Tonsila Palatina/inmunología , Adenosina Desaminasa/metabolismo , Niño , Preescolar , Desoxicitidina Quinasa/metabolismo , Humanos , Nucleósidos/metabolismo , Tonsila Palatina/efectos de los fármacos , Tonsila Palatina/enzimología , Timidina Quinasa/metabolismo , Tonsilitis
3.
Biochem Biophys Res Commun ; 203(3): 1378-84, 1994 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-7945284

RESUMEN

2-chloro-2'-deoxyadenosine (Cl-dAdo) is a potent drug against hairy cell leukemia and other lymphomas. Its effects on the metabolism of labeled deoxycytidine (5-[3H]dCyd) and deoxythymidine ([3H]dThd) were investigated in short term cultures of human lymphocytes. In the presence of Cl-dAdo, a more pronounced inhibition of DNA synthesis was found, accompanied with a much higher accumulation of radioactivity in dTTP than in dCTP. This difference disappeared in the presence of exogenous dThd. Analysis of intracellular metabolites of 5-[3H]dCyd showed an increase in [3H]dCTP used for liponucleotide biosynthesis and a decrease in [3H]dUMP formation in the presence of Cl-dAdo, suggesting the possible inhibition of dCMP deaminase.


Asunto(s)
Cladribina/farmacología , ADN/biosíntesis , Desoxicitidina/metabolismo , Linfocitos/efectos de los fármacos , Timidina/metabolismo , Células Cultivadas , Niño , Preescolar , Nucleótidos de Desoxicitosina/metabolismo , Nucleótidos de Desoxiuracil/metabolismo , Humanos , Cinética , Linfocitos/citología , Linfocitos/metabolismo , Tonsila Palatina , Nucleótidos de Timina/metabolismo , Factores de Tiempo , Tritio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...